On air · 1 of 3 networks
CereVasc
- cerevasc.com
- Healthcare & Life Sciences
- US
- 40 employees
CereVasc’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 37. Watch CereVasc with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 37 | Checked 30 Oct 2026 | See all 37 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 25 Oct 2026 | Collect them with the API → |
CereVasc has 37 live LinkedIn ads. We recorded no Google ads on 25 Oct 2026.
Latest ads
- LINKEDIN · IMAGERecorded 13 Sept 2026
At the Congress of Neurological Surgeons (CNS) Annual Meeting, CereVasc Co-Founder and CEO Daniel Levangie presented “From Concept to Clinic: The Journey to Breakthrough Device Development,” sharing what it takes to bring a breakthrough device from idea to patient impact. He explored the realities of early design, clinical validation, and the collaboration that fuels true innovation. Speaking to the next generation of neurosurgeons, he reflected on lessons learned along the journey and the future of neuro-endovascular innovation. #CNS2025 #Neurosurgery #MedTech #Innovation #BreakthroughDevice
- LINKEDIN · VIDEORecorded 13 Sept 2026
The STRIDE clinical trial is evaluating the safety and efficacy of the eShunt System®—a minimally invasive treatment for normal pressure hydrocephalus (NPH). During a recent webinar, Ricardo Hanel, MD, PhD, explained the procedure and how the device works. Caution: The eShunt System is an investigational device and is not available for sale within or outside the US. Learn More: https://lnkd.in/enUSkiF5 #NPH #Neurosurgeons #Neurologists #Neurosurgery #Neurology #Hydrocephalus #HydrocephalusAwareness
- LINKEDIN · VIDEORecorded 13 Sept 2026
The STRIDE clinical trial is evaluating the safety and efficacy of the eShunt System®—a minimally invasive treatment for normal pressure hydrocephalus (NPH). During a recent webinar, Ricardo Hanel, MD, PhD, explained the procedure and how the device works. Caution: The eShunt System is an investigational device and is not available for sale within or outside the US. #NPH #Neurosurgeons #Neurologists #Neurosurgery #Neurology #Hydrocephalus #HydrocephalusAwareness
- LINKEDIN · VIDEORecorded 13 Sept 2026
With 26 active sites and more coming soon, the STRIDE clinical trial is the largest study for the treatment of normal pressure hydrocephalus (NPH). STRIDE is evaluating the eShunt System®— the first endovascular treatment approach for people with NPH. Watch to find a nearby trial site. Caution: The eShunt System is an investigational device and is not available for sale within or outside the US. Learn more: https://lnkd.in/enUSkiF5 #NPH #Neurosurgeons #Neurologists #Neurosurgery #Neurology #Hydrocephalus #HydrocephalusAwareness
- LINKEDIN · VIDEORecorded 13 Sept 2026
The STRIDE clinical trial is evaluating the safety and efficacy of the eShunt System®—a minimally invasive treatment for normal pressure hydrocephalus (NPH). During a recent webinar, Ricardo Hanel, MD, PhD, explained the procedure and how the device works. Caution: The eShunt System is an investigational device and is not available for sale within or outside the US. #NPH #Neurosurgeons #Neurologists #Neurosurgery #Neurology #Hydrocephalus #HydrocephalusAwareness
- LINKEDIN · VIDEORecorded 13 Sept 2026
The FDA recently designated the eShunt® System as a Breakthrough Device* because of its potential to provide improved treatment for normal pressure hydrocephalus (NPH). Charles Matouk, MD, explains how this designation marks a positive step for people with NPH. *Breakthrough designation does not imply approval or guaranteed safety and effectiveness. Learn more about the STRIDE clinical trial: https://lnkd.in/eBJe3JrY #NPH #Neurosurgeons #Neurologists #Neurosurgery #Neurology #Hydrocephalus #HydrocephalusAwareness
6 of 37 adsSign up to see every CereVasc ad, filter by format and date, and get alerts on new ones.
See all 37 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.